|
|
|
|
|||||
|
|
|
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 17th:
ProKidney Corp. PROK: This clinical-stage biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.8% over the last 60 days.
ProKidney Corp. price-consensus-chart | ProKidney Corp. Quote
ProKidney’s shares gained 371.7% over the last three months compared with the S&P 500’s advance of 18.2%. The company possesses a Momentum Score of A.
ProKidney Corp. price | ProKidney Corp. Quote
Roku, Inc. ROKU: This operator of a TV streaming platform has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.3% over the last 60 days.
Roku, Inc. price-consensus-chart | Roku, Inc. Quote
Roku’s shares gained 55.4% over the last three months compared with the S&P 500’s advance of 18.2%. The company possesses a Momentum Score of B.
Roku, Inc. price | Roku, Inc. Quote
Pharming Group N.V. PHAR: This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 7% over the last 60 days.
Pharming Group N.V. Sponsored ADR price-consensus-chart | Pharming Group N.V. Sponsored ADR Quote
Pharming’s shares gained 26.6% over the last three months compared with the S&P 500’s advance of 18.2%. The company possesses a Momentum Score of B.
Pharming Group N.V. Sponsored ADR price | Pharming Group N.V. Sponsored ADR Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).
| 1 hour | |
| 3 hours | |
| 5 hours | |
| 7 hours | |
| 8 hours | |
| 9 hours | |
| 10 hours | |
| 11 hours | |
| 15 hours | |
| Jul-16 | |
| Jul-16 | |
| Jul-16 | |
| Jul-16 | |
| Jul-16 | |
| Jul-16 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite